Skip to main content
PTGX logo

PTGX · Protagonist Therapeutics, Inc · Held by Funds

Track PTGX — free
$127.16 +2.49 (+2.00%) At close · Nov 18 Q4 2020 earnings call transcript
Market Cap
$8.30B
Shares
65.27M
Volume · Nov 18 433.18K Avg daily vol (3M) 666.83K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of PTGX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 29.31% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 4.74% 3,093,122
Index ETFs 24.57% 16,034,968
Active ETFs 0.61% 400,449
Active funds 18.05% 11,782,586
Unclassified 0.09% 55,727
All registered funds 48.06% 31,366,852
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding PTGX

413 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 413 positions
Key facts CIK 1377121 CUSIP 74366E102 13F (30d) 382 filings 356 filers Visit website Investor relations